MedPath

Ambulatory blood pressure monitoring vs home based blood pressure monitoring in high risk pregnant females

Not Applicable
Registration Number
CTRI/2022/06/042956
Lead Sponsor
AIIMS Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All antenatal females at their first visit in OPD, will be screened for the risk of developing HDP in the present pregnancy. They will be categorized into high risk or low risk for HDP on the basis of presence of one of the following criteria:

Presence of any one of the following severe factors:

1.Hypertensive disease during a previous pregnancy

2.Chronic kidney disease

3.Autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome

4.Type 1 or type 2 diabetes

OR

Presence of more than 1 of the following moderate factors:

1.first pregnancy

2.age 35 years or older

3.pregnancy interval of more than 10 years

4.body mass index (BMI) of 30 kg/m2 or more (pre-pregnancy weight or weight at first visit)

5.family history of pre-eclampsia

6.multi-fetal pregnancy

Exclusion Criteria

EXCLUSION CRITERIA:

1.High risk antenatal females with office BP > or equal to 150/100 mmHg at first antenatal visit

2.Chronic hypertension

3.Already diagnosed HDP

4.Antenatal females not willing to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the overall incidence of Hypertensive disorders of pregnancy in high risk antenatal females diagnosed with ABPM v/s those diagnosed with HBPM.Timepoint: 18 months for recruitment
Secondary Outcome Measures
NameTimeMethod
To compare mean number of weeks of developing hypertensive disorder of pregnancy after enrollment in studyTimepoint: 18 months;To compare the adverse perinatal outcome in HDP diagnosed females in both the groups.Timepoint: 18 months for recruitment
© Copyright 2025. All Rights Reserved by MedPath